The FDA approved TheracosBio’s Brenzavvy as a treatment for type 2 diabetes. But before it won a regulatory nod for controlling blood glucose in adults, it was approved at a different dose (with flavor) as a veterinary product.
Mobidiag offers multiplex testing, which is the ability to test for multiple pathogens from a single test sample. Hologic said the acquisition will enable the company to enter the acute care test market, which is projected to grow in a post-pandemic world.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The EUAs follow the ones the agency gave last week to Roche and Thermo Fisher Scientific. The agency is also allowing states to take greater responsibility for authorizing tests for the SARS-CoV-2 virus.
Boston Scientific may have purchased Swiss structural heart company Symetis for many reasons but one could very well be that the Lotus aortic valve is not ready for prime time.
Boston Scientific is testing microspheres coated with a chemotherapy drug that can be delivered at the tumor site in the liver to provide an alternative to chemotherapy drugs with its attendant side effects and costs.
Cosman Medical, which makes RF generators and electrodes among other things, will become part of Boston Scientific's neuromodulation business.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
GE Healthcare Life Sciences is moving its U.S. headquarters to Marlborough, Massachusetts, hiring another 220 life sciences and biotech workers as part of the project’s expansion, according to a statement. The company is spending $21 million on the new, 160,000-square-foot site. It’s slated to open next spring, and will employ more than 500. GE Healthcare Life […]